US Nuclear CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
US Nuclear Corp. (UCLE) reported a significant reduction in its net loss for fiscal year 2024, driven by improved gross margins and lower other expenses, despite facing substantial doubt about its ability to continue as a going concern and acknowledging ineffective internal controls.
OTC.Pink
US Nuclear Corp.'s annual report reveals a revenue increase of 6.68% in 2023, but also a significant widening of net losses compared to the previous year.